Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
Renata Sokolik,1,* Milena Iwaszko,2,* Jerzy Świerkot,1 Barbara Wysoczańska,2 Lucyna Korman,1 Piotr Wiland,1 Katarzyna Bogunia-Kubik2 1Department of Rheumatology and Internal Medicine, Wrocław Medical University, Wrocław, Poland; 2Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld...
Saved in:
Main Authors: | Sokolik R (Author), Iwaszko M (Author), Świerkot J (Author), Wysoczańska B (Author), Korman L (Author), Wiland P (Author), Bogunia-Kubik K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term survival of methotrexate in psoriatic arthritis
by: N. Battafarano, et al.
Published: (2011) -
The association of interleukin-6 (−174 G/C) polymorphism with risk of chronic kidney disease and erythropoietin hyporesponsiveness
by: Noha Alnair Abdelrhman, et al.
Published: (2022) -
Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: A case-control study and meta-analysis
by: Sajad Ahmad Dar, et al.
Published: (2017) -
Interleukin-6 G-174C gene polymorphism and susceptibility to upper respiratory tract infection among endurance athletes
by: Farzad Zehsaz, et al.
Published: (2014) -
Updates on the Pathophysiology and Therapeutic Potential of Extracellular Vesicles with Focus on Exosomes in Rheumatoid Arthritis
by: Gavriilidi IK, et al.
Published: (2024)